Contraceptive Choice: Safety vs Efficacy

Item

Title
Contraceptive Choice: Safety vs Efficacy
Creator
Sathyamala
Date
1987
extracted text
(<S4>

lOOOM-SECnVDI'Jtfa

teo Hnvj;: /aj.-jniwjoo
,
CONTRACEPTIVE CHOICE ; SAFETY VS EFFICACY.
(,'ty^ckground paper prepared, for the XIII Annual Meet of MFC, Jan 1987).
- Sathyamala
There is a general belief that contraceptives reduce maternal morta­
lity rates considerably. Statements such as "Like! all medicines, birth control pills occasionally cause

serious problems in certain perons.... Of the 15,000 women, who
become pregnant, 75 are likely to die from problems of pregnancy

or child birth; of the 15,000 women who take the birth control
pills only one is likely to die from problems related to having
taken the pill. Conclusion; It is much safer to take the pill
than to be’come pregnant. "

are made to highlight what a boon the modern day contraceptives are
to the procreating women. Even when attempts are made to discuss _>
complications or mortality rates in relation to contraceptive methods,

they are usually rationalised as'"..It may be emphasised that though
the mortality of interval sterlization is much higher than that of

post partum ..sterlizations, the mortality of either of the two proce­
dures is much lower than the maternal mortality for this country

(India) which is the risk the patient (emphasis added) would be
exposed to if she were not sterlized." (2). Complacency is also

expressed in statements like-contraceptive 'X1 has no life threaten­
ing side effects and therefore it is safe.

The underlying assumption

in all these statments is that the contraceptive methods that are
currently being promoted are far safer than the 'risk' of becoming
pregnant.

While it may be true that child bearing adds a certain risk to the

woman population, it becomes a definite risk in only those population
mortality rate : and it is the
purpose of this paper to present the hypothesis that while contrace­
ptive use may theoretically decrease the possibility of pregnancy

which has an already high overall

related deaths, the quantum of morbidity it produces is far too high
to justify its wide use in developing countries where the very
factors responsible for the high maternal mortality rate would lead

to an increase in mortality due to contraceptive use as well.

Morbidity load due to the currently available female methods of
contraception;
An estimate of the probable morbidity load can be made on the basis

of the data available on the incidence rates of complications arising,
from the use of contraceptive methods.‘ The morbidity rates have been
calculated on the number of acceptors in 1980-81.

-2-

Con treceptive
method

Morbidity

Incidence

lUCDs

Bleeding
and pain

10-15/100
users

No. of accepNo. of women
tors in.-1980-81 who would
have suffered
ill health
6,00,000

PID

10/100
users
Infertility 10/100
users
Ectopic
pregnancies 0.8 to 4% of
method failure
Spontaneous 50% of method
abortions
failure
Perforation 1/2500 users
of uterus
Tubectomy

Post op.
menorrhagia 5.1%
Pelvic
infections

ii

60,000

ii

60,000

ii

240 to 1200

ii

15,000

n

240

1,550,000
!l

12.42/1000

60,000 to
90,000.

79,050
19,251

.Total morbidity due to these two methods

3

293781

Total number of acceptors

S

2150000

Morbidity rate due to these two methods

s 137/1000 acceptors
3 326-3^7/1000
acceptors

Morbidity rate due to IUCD alone
(ref No.3)

The incidence rates used in these calculations are probably an

underestimation of the actual incidence in rural areas. The calcu­
lations have also not taken into account
the total morbidity
subsequent to contraceptive failure. It shoulc, be noted that the
complication rates for tubectomies are from surgeries performed in

teaching hospitals. The incidence rates in the field situation ie.
Primary Health Centres and FP Camps would probably be much higher

than the ones quoted.

The morbidity due to oral pill use was not included in the table
because the acceptance and the continuation rate for oral pill use

in India has generally been very low.

Infact it is so low that oral

pill use rate is not included in the assessment of eligible couple
protection rate. In 1983, to overcome the problem of the non accep­
tance of the pill, the Health Ministry came up with the bright idea
of distributing the pills through the Village Health Workers. This
plan was dropped later because of the opposition from the Indian
Women's Scientists Association on the grounds that such a plan would
neither be safe nor effective.

However from the report of the

'Revised Strategy for National Family Welfare Programme', it appears

that there are definite plans to expand the use of the pills through

-3—

” social marketing and by using a new cadre of workers, the'Village

Level Women Volunteers Corps'.

Reports have also come from several

parts of the country that this new cadre has swung into action and that
the pill is being promoted through the door to door sales technique*.

An even more worrying aspect of the strategy is for the first time an
official policy states "acceptance of oral pills in rural areas can
be expanded if medical consultation is not prescribed."(4)

The potent_al morbidity and mortality due to oral pill use should this

scheme become successful can be seen from data available from other
countries.

The following table presents the episodes of hospitalization

and mortality rates in a group of oral pill users from UK.
Serious side effects associated with rhe use of
combined oral contraceptive.
Excess morbidity and mortality per year
100,000 users
Deaths.
Diagnosis Hospitalizations

Side effect

S troke

35

9.7

125

70

3.4

17

17

8.0

79

79

31

Deep Vein Thrombosis
or Pulmonary Embolism
Superficial or unspeci­
fied thrombosis
Heart attack and other
non-rheumatic heart Dis.
Gall bladder Disease
'(surgically confirmed)

91

Kidney Infection

383

Benign liver tumor
Hypertension

1
406

1

0.1
1.7

Total

1133

202

22.9

(Ref. No. 5)
This data indicates that “one out of every 500 pill users are hospita­
lized annually due to serious side effects caused by this method. An

estimated one out of every 5000 users die annually from pill caused

strokes, thromboses and heart attacks... roughly two thirds are among
smokers and one third among non smokers".(5)
It is generally alleged that these risks do not apply to Asian Women

because they do not have the same problems if heart attack and throm­
botic disease.

This assumption is unfounded because according to the

ICMR report of 1981,"...Available data on Indian women with CVD(cardio

vascular disease) show that though their .lipid levels were higher- than
the normal Indian women, the levels were far below their Western
counterparts".(6) and concludes that epidemiological studies are needed
to confirm if Indian women using oral contraceptive might be at a lower
risk of developing CVD. Epidemiological studies from Hong Kong have

-4-

shown that there has been an increase in heart ailments among women
between 1969-75 or since the pill was introduced.

If the pill progra­

mme indeed becomes successful one could still expect complacency
because Indian women especially from the rural areas will neither be
diagnosed nor hospitalized to tire same extent as their British counter­
parts for obvious reasons.

But one can say witii surety that should

the programme become successful the mortality and morbidity rate in
women user.- under unsupervised conditions will be very high.

A recently released report (1982) from the Centre of Disease Control
USA has shown that for the first time- in che USA contraceptive-

related deaths outnumber pregnancy - related deaths. This could
very well be the situation in India if the trend towards pushing
even more hazardous contraceptives persist.

The report of the ‘Revised Strategy for National Family Welfare

Programme1 makes its intentions very clear.

Under 'Family Planning

Research' it states
"New technologies like injectables, sub-dermal implants,etc,
are currently undergoing trials before introduction in the

programme.

The procedures and the protocols and the time

scales of induction of new technologies will be revised to

enable faster introduction of such technologies in the
programme." "Development of simple, reversible, safe and
long acting contraceptives such as the anti-fertility vaccine.

would seem to offer great potential.

Research efforts in

developing such a vaccine will receive high priority."(7)
Anyone with even a rudimentary knowledge of the mechanism of action

of these- methods would know that -the complications arising out of
their wide-use will be of a magnitude never witnessed before in

contraceptive history. An added problem with these contraceptives
is that the morbidity and mortality risks will not be confined to
the women alone but is going to be extended to their progeny as well.

The question that gets posed is why then this strange attachment to

hazardous contraceptives when available data already indicates that
they are a definite threat to women's lives. This is when the red

herring in the form of "effectiveness" is thrown up to confuse every­
one.

It is stated that more and more invasive a method is better and

better is its effectiveness because it will act at so many levels
that conception will not stand a chancel

*

The following taele shows that if one compares the lowest observed

failure rates for the currently available methods, the effectiveness
is almost similar.

-5-

Method

Lowc-st observed failure rate (%)

Tubal sterlization

0.4

Vasectomy

0.4

Combined pills
IU3

0.5

Condom

2
2

Diaphragm with spermicide
Cervical cap

Fertility awareness
(Ref. No.8)

1.5

2
2 -20-

That means that theoretically at least in a well'controlled'

situation the effectiveness of invasive contraceptives are very

similar to the non-invasive barrier methods.

The problem comes

when effectiveness is discussed in terms of actual use.

For instance,

if a woman takes the pill everyday and does not miss even once then
the theoretical effectiveness would apply to her.

But in a real

situation in a group of pill takers the effectiveness would be

influenced- by the irregularity or the regularity with which each
member takes the pill. Hence the actual failure rate can range
from 5 (IUD) to 10 (Condom) to 19 (Diaphragm). This- is what the
population' experts are really concerned abouts the performance of

a method in a population which they may not be able to "control".
Hence the attachment to invasive methods which hopefully will not
be affected by the vagaries of human nature.

The medical establishment however rationalises in a different way
the need for a method whose theoretical use comes closer to the
actualise. It is argued that if the failure rate is high with
contraceptive use, the women accepting a method with the high
failure rate would continue to run the risks of pregnancy, A comparison of cumulative risk of deaths associated with fertility
control methods which includes both maternal deaths susequent to
contraceptive failure and method-related deaths show that despite
the additional risk of high failure rates, condoms backed by abortion
is the safest method available.

Cumulative Risk of Death Associated with Ferti1ity Control Methods
(per 100,000 nonsterile womenT
Method
15-34
35-39
40-44
15-44
Pill/smoker
257
588
132
977
Pi11/n onsmoke r
70
21
160
251
Rhythm
36
14
18
68
Diaphragm/spermicide
28
14
11
53
IUD
10
25
10
45
Abortion
26
41
.9
6
Condom
19
2
2
23
C on dom/abo rti on
1
1
1
1
No method
192
129
141
462
(Ref. No.9)

It is obvious that if a Family Planning policy is really concerned
with the health of the women, then it would stop viewing hysterically,
the possibility of an inadvertant pregnancy due to contraceptive

failure as a national disaster.

Till such time it docs that, the

attempt of the population controllers will be to develop methods
which tend towards the mythical 100% effectiveness leaving the

concept of safety to the four winds.

The question that remains to be answered is - is pregnancy really
such an enormous risk that the wide use

hazardous contraceptives

can not only be justified but should in fact be promoted in the
. interests of women?

In this context it must be remembered that

while comparing mortality and morbidity risks in contraceptive use
and pregnancy there are two different populations at risk.

Only

women who become pregnant can die of pregnancy related causes.
A much larger number of women is at a risk of death from contrace­

ption related causes, and this population would have already faced
the risks of becoming pregnant before they accept a method. Finally
it must also be remembered the complications arising from contra­
ceptive use are generally long-term effects and could lead to
permanet disability.

Notes and References s
1. "Where there is no doctor",Indian adaptation, by Sathyamala, VHAI.
2. ±CMR Bulletin,June 1982, P 59.
3.

(a) Incidence Rate(Ir) for bleeding and pain,'Contraceptive
Technology, 1986-1987,1 13th Revised Edition, Irvington
Publishers, p 202.

(b) IR for PID, 'Population Reports,

'Series B, No.4,July 1982,

p. B-121, "Other recent studies in developed countries have
found the relative risk of developing PID ranges from 1.5

to 10 for IUD users." I have takenthe higher figure because

in developing countries it must be higher than this.
(c) IR for infertility, population Reports, Series B, No.4,July

l,9flZ, Thu s~._ec topic. pregnancy .or inf ertiJLi_ty /jia^-rgicu-r even
after only one episode (of PID in the falTLctpian tunes) tl
(d) IR for ectopic pregnancies, Population Reports,Sereies B,
No.4, p, B-125.

(e) IR for spontaneous abortions, Population Reports, SeriesB,
No. 4 p. B 124. "About 50% of uterine pregnancies spontaneously

abort if the device is not removed". In some studies over
half of the spontaneous abortions inlUD users is in second
trimester and a spetic second trimester abortion is 26 times

more likely in women with an IUD in place.
in actual users of IUD is 5,'ICO.

The failure rate

»'
<•

-y-

(f) IR for perforation of uterus, Contraceptive Technology,
1986-1987, p 208.

U) IR for post op. menorrhagia and Pelvic infections, ICMR
Bulletin June 1982, p 59.
4.

"Revised Strategy for National Family Welfare Programme, II
GOI.- 1986 (?) p. 6.

5.

"Con traceptivc-s and Developing Countries ; the role of-Barrier

Methods," Bruce and Schearer, Inter" "■tional Symposium on
Research on the Regulation of human fertility, Sweden, Feb.1983,
p 407.

6.

ICMR Bulletin, Dec. 1981.

7.

"Revised Strategy for National Family Welfare Programme,"
GOI 1986(?), p 123.

8.

Contraceptive Technology, 1986 - 1987, p 102.

9.

"Out look", Vol 1, No. 3, Sept. 1983, p 4, Figures adapted
from Ory of the US Centres of Disease Control.

Position: 352 (12 views)